Impact of aortic valve replacement in symptomatic low-risk patients with less than severe aortic stenosis.

ABSTRACT:

Objective

To evaluate whether transcatheter or surgical aortic valve replacement (TAVR or SAVR) affects clinical and haemodynamic outcomes in symptomatic patients with moderately-severe aortic stenosis (AS).

Methods

Echocardiographic evidence of severe AS for enrolment in the Evolut Low Risk trial was based on site-reported measurements. For this post hoc analysis, core laboratory measurements identified patients with symptomatic moderately-severe AS (1.02, 3.0ResultsModerately-severe AS was identified in 113 out of 1414 patients (8%). Baseline AVA was 1.1±0.1 cm², peak velocity 3.7±0.2 m/s, MG 32.7±4.8 mm

SUBMITTER: Ito S 

PROVIDER: S-EPMC10186477 | biostudies-literature | 2023 May

REPOSITORIES: biostudies-literature